Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (76658)	12/27/1999 3:34:00 PM
From: Mr. Big	Respond to of 120523

Pre-split CMRC is up $210 points today.

To: Jenna who wrote (76658)	12/27/1999 3:42:00 PM
From: Yak-attack	Read Replies (1) \| Respond to of 120523

From CBS marketwatch: concerning NYSE:HQH (biotech incubator) Ailon Grushkin, a CBS.MarketWatch.com viewer, called in to say one biotech incubator, H&Q Health Care Investors, holds stakes in as many as 20 privately held biomedical companies. The closed-end fund (HQH: news, msgs), at 18 3/8, trades at a discount to its net asset value, or the worth of its holdings. Hambrecht & Quist Capital Management Inc. manages the fund, which trades on the New York Stock Exchange. Securities and Exchange Commission filings show the net asset value of the fund as of Sept. 30 was $21.77 a share. Since then, large biotechnology stocks as a group have risen about 45 percent in the U.S. stock market. So the value of the fund's holdings is likely to be higher. See the latest filing for a list of the fund's holdings.